How Is Ovarian Cancer Diagnosed?

This content has been reviewed and approved by

Maurie Markman, MD
Vice President, Clinical Research
MD Anderson Cancer Center
University of Texas
 

To diagnose ovarian cancer, your physician may order diagnostic tests, including:

  • Computed tomography (CT or CAT scan) - a noninvasive procedure that takes cross-sectional images of the internal organs to detect any abnormalities that may not show up on an ordinary x-ray. The CT scan may find enlarged lymph nodes—a possible sign of a spreading cancer or of an infection.
  • Lower gastrointestinal (GI) series - x-rays of the colon and rectum using a contrast medium called barium.
  • Intravenous pyelogram (IVP) - x-ray of the kidneys and ureters taken after the injection of a dye.
  • Biopsy - a procedure in which tissue samples are removed from the body for examination under a microscope to determine if cancer or other abnormal cells are present. The diagnosis of cancer can only be confirmed by a biopsy.

Accurate surgical evaluation is necessary for nearly all patients with ovarian cancer. This can be accomplished during either a laparotomy (a procedure in which an incision is made in the abdomen to expose the abdominal contents for diagnosis or surgery) or a laparoscopy (a less invasive procedure in which a viewing device is inserted into the abdominal cavity and biopsies are taken) to determine the stage of the cancer.

This content was last reviewed August 15, 2010 by Dr. Reshma L. Mahtani.
Latest Ovarian Cancer News
EU OKs Roche's Avastin for ovarian cancer

December 23, 2011 — ZURICH (Reuters) - The European Commission has approved Roche's drug Avastin for treating women with newly diagnosed, advanced ovarian cancer, offering new options to sufferers previously limited to surgery and chemotherapy.

Better ovarian cancer screening, still no answers

November 29, 2011 — NEW YORK (Reuters Health) - After disappointing results earlier this year, researchers say new study findings from Kentucky offer a bit of hope for ovarian cancer screening.

Scientists find new ovarian cancer gene

August 8, 2011 — LONDON (Reuters) - Women who carry a faulty copy of a gene called RAD51D have an almost one in 11 chance of developing ovarian cancer, scientists said on Sunday in a finding they called the most significant ovarian cancer gene discovery for more than 10 years.

Select news items provided by Reuters Health